Ajanta Pharma gets USFDA nod for generic asthma treatment drug – Economic Times

Ajanta Pharma gets USFDA nod for generic asthma treatment drug
Economic Times
NEW DELHI: Drug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules used for prevention and treatment of asthma and to relieve symptoms of seasonal hay fever. The company has …

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.